IVD PRODUCT

MammaTyper®

Molecular subtyping tool for breast cancer based on quantitative mRNA detection

Highlights

  • Quantitative mRNA detection of four biomarkers
  • Molecular subtyping at mRNA level
  • LRP recurrence risk score

CLINICAL VALUE

Molecular subtyping at mRNA level:

Further distinguish the prognosis of breast cancer patients with Luminal type by molecular subtyping at mRNA level.

LRP recurrence risk score:

LRP score can screen patients with low risk of relapse (defined as RS≤25) in a cost-effective way.

PREFERRED POPULATION

  • ER+/HER2- patients with early stage of breast cancer